Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Metastatic Merkel Cell Carcinoma
NCT00068783Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2003
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in Merkel cell carcinoma (MCC), sponsored by National Cancer Institute. Started Oct 2003; status: completed.
02
Drugs
03
Conditions
Merkel cell carcinoma (MCC)
Beyond the preview
Go deeper on NCT00068783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00068783.